Michael F Mahoney is Chairman, President & CEO at Boston Scientific. OQRO lists 30 transactions filed with the SEC under this name, the latest on Aug 5, 2026, each linked to the official Form 4.
Chairman, President & CEO
Disclosures on record
30
Companies involved
2
1 buy, median -8.4% vs S&P 500, beat it 0 of 1 time.
Average -8.4% vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Aug 5, 2026 to Aug 5, 2026, measured from the first close after the filing. No purchase has reached 90 days yet, so 30 days is shown. Past results, not a forecast.
Stock since the trade -12.4% · S&P 500 +2.3% · to Oct 5
The boss of Boston Scientific paid $9M out of pocket for Boston Scientific shares. 3 other people at Boston Scientific bought some too, in the same month. The Boston Scientific shares held grew by 13%.
Not classified as an open-market trade.
Gift or transfer — classified separately from trades.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
CEO sold ~$14.9M of Boston Scientific
Scheduled in advanceCEO sold ~$113K of Boston Scientific
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Compensation award — excluded from discretionary-purchase analysis.
Gift or transfer — classified separately from trades.
Gift or transfer — classified separately from trades.
Gift or transfer — classified separately from trades.
